| Childhood vaccine acceptance and refusal among Warao Amerindian Caregivers in Venezuela; A qualitative approach J Burghouts, B Del Nogal, A Uriepero, PWM Hermans, JH de Waard, ... PloS one 12 (1), e0170227, 2017 | 47 | 2017 |
| Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia PE Morande, M Sivina, A Uriepero, N Seija, C Berca, P Fresia, AI Landoni, ... Blood, The Journal of the American Society of Hematology 133 (19), 2056-2068, 2019 | 19 | 2019 |
| LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL D Prieto, N Seija, A Uriepero, T Souto‐Padron, C Oliver, V Irigoin, ... British journal of haematology 182 (4), 521-525, 2018 | 12 | 2018 |
| Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies K Maharaj, A Uriepero, E Sahakian, J Pinilla-Ibarz Frontiers in Immunology 13, 943354, 2022 | 11 | 2022 |
| TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression ME Marquez, S Sernbo, E Payque, R Uria, JP Tosar, J Querol, C Berca, ... Cancers 14 (7), 1676, 2022 | 7 | 2022 |
| Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis JC Chavez, A Grajales, J Sandoval-Sus, E Turba, L Nodzon, ... Clinical Lymphoma Myeloma and Leukemia, 2024 | | 2024 |
| Characterization of T-cell metabolic defects in chronic lymphocytic leukemia preclinical model W Gamal, M Mediavilla-Varela, K Maharaj, A Uriepero, V Kunta, ... Cancer Research 83 (7_Supplement), 4843-4843, 2023 | | 2023 |
| Targeting Inflammatory Pathways to Reverse Immunosuppressive Tumor Microenvironment in Chronic Lymphocytic Leukemia A Uriepero, M Mediavilla-Varela, K Maharaj, W Gamal, ME Marquez, ... Blood 140 (Supplement 1), 6988-6989, 2022 | | 2022 |
| Metabolic Abnormalities Associated with T-Cell Exhaustion in CLL Eµ-TCL1 Murine Model W Gamal, M Mediavilla-Varela, K Maharaj, A Uriepero, V Kunta, ... Blood 140 (Supplement 1), 6994-6995, 2022 | | 2022 |
| Efficacy and immune profiling of PI3K delta inhibitor zandelisib (ME-401) in a preclinical chronic lymphocytic leukemia (CLL) model K Maharaj, M Mediavilla-Varela, JJ Powers, S Wiley, A Uriepero, ... Cancer Research 82 (12_Supplement), 5496-5496, 2022 | | 2022 |
| Efficacy of Vecabrutinib Treatment in a Murine Model of Sclerodermatous Graft-Versus-Host-Disease K Maharaj, M Mediavilla-Varela, A Uriepero, JA Fox, P Taverna, W Gamal, ... Blood 138, 1685, 2021 | | 2021 |
| MicroRNAome analysis of unmutated and progressive CLL patients identify a set of microRNAs associated with TGF-beta pathway impairment during disease progression M Elena Marquez, S Sernbo, C Berca, A Uriepero, C Guillermo, ... LEUKEMIA & LYMPHOMA 61, 134-135, 2020 | | 2020 |
| Pyroptosis as a drugable cell death pathway in Chronic Lymphocytic Leukemia: the other side of inflammation. F Rammauro, A Uriepero, D Prieto, M Elena Marquez, C Berca, ... LEUKEMIA & LYMPHOMA 61, 136-137, 2020 | | 2020 |
| Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia P Morande, M Sivina, A Uriepero, N Seija, C Berca, P Fresia, AI Landoni, ... LEUKEMIA & LYMPHOMA 61, 130-132, 2020 | | 2020 |
| High absolute monocyte count at diagnosis identifies a subset of patients with shorter time to first treatment among low risk CLL-IPI M Victoria Irigoin, A Carolina Oliver, V Remedi, A Ines Landoni, ... LEUKEMIA & LYMPHOMA 61, 254-256, 2020 | | 2020 |
| AID and LPL mRNA expression are useful additional markers that improve CLL-IPI prediction in progressor patients V Remedi, AI Landoni, MV Irigoin, AC Oliver, C Guillermo, L Diaz, ... LEUKEMIA & LYMPHOMA 61, 243-244, 2020 | | 2020 |
| Estudio de mecanismos moleculares asociados a la proliferación y sobrevida del clon tumoral en la Leucemia Linfoide Crónica: hacia la identificación de un posible blanco … A Uriepero | | 2020 |
| Desenmarañando la progresión de la LLC en pacientes no mutados:: relación entre la expresión funcional de la citidina deaminasa inducida por activación con la evolución de la … N Seija, J Sepulveda, D Prieto, P Morande, A Uriepero, M Navarrete, ... Revista Hematología 22 (2), 33-35, 2018 | | 2018 |
| Unraveling CLL progression in unmutated patients: linking functional AID expression with disease evolution P Oppezzo, N Seija, D Prieto, J Sepulveda, P Morande, A Uriepero, ... LEUKEMIA & LYMPHOMA 58, 207-208, 2017 | | 2017 |
| AID and LPL mRNA expression identify patients with different clinical outcomes within UM CLLs P Oppezzo, A Ines Landoni, V Irigoin, C Oliver, V Remedi, G Borelli, ... LEUKEMIA & LYMPHOMA 58, 202-203, 2017 | | 2017 |
